← All stocks

Eledon Pharmaceuticals, Inc.

ELDN Net buying

CIK 0001404281 #3653 in the set updated 21 Sep 2026

Bought (120 mo)

$7.46M

out of their own pocket, the only kind of buying there is

Sold (120 mo)

$2.63M

$0.00 on a plan · $0.00 straight out of an exercise

Sold at will

$2.63M

10 of 10 sales

Net

+$4.83M

+$4.83M against sales at will

By person

18 insiders · 36 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Chimovits Erez

Director

$2.00M (1)

—

+$2.00M

3,183,314

3.92%

$8.27M

+25.5%

Logos Global Management LP entity

10% owner

$2.34M (7)

$345.56K (2)

+$2.00M

224,071

0.2757%

$581.89K

+54.5%

FLESHER GREGORY J.

Chief Executive Officer

$589.00K (1)

$28.57K (2)

+$560.43K

156,918

0.1931%

$407.50K

+175.8%

TURKEL CATHERINE C.

President

$275.34K (4)

$18.61K (2)

+$256.73K

89,467

0.1101%

$232.34K

+567.3%

OrbiMed Israel GP Ltd. entity

10% owner

$2.00M (1)

$2.23M (1)

−$225.89K

73,650

0.0906%

$191.26K

—

OCAMPO CHRISTINE

See Remarks

$100.00K (1)

—

+$100.00K

21,590

0.0266%

$56.07K

+86.4%

Little Paul Sean

Chief Financial Officer

$88.70K (1)

—

+$88.70K

10,000

0.0123%

$25.97K

—

Gros David-Alexandre C

Chief Executive Officer

$57.83K (3)

—

+$57.83K

168,663

0.2076%

$438.00K

—

Kuwahara Jon

See Remarks

—

$10.30K (2)

−$10.30K

5,974

0.0074%

$15.51K

—

Perrin Steven

President

$2.60K (1)

—

+$2.60K

81,215

0.0999%

$210.91K

—

LIFESCI INDEX PARTNERS LLC entity

10% owner

—

$540.00 (1)

−$540.00

1,065,867

1.31%

$2.77M

0.0%

BVF PARTNERS L P/IL entity

10% owner

— (6)

—

$0.00

220,460

0.2713%

$572.51K

—

Katkin Keith

Director

—

8,575

0.0106%

$22.27K

—

Robinson James A. Jr.

Director

—

3,430

0.0042%

$8.91K

—

McBride John S.

Director

—

3,430

0.0042%

$8.91K

—

Hillson Jan

Director

—

3,430

0.0042%

$8.91K

—

Kirk Allan

Director

—

3,430

0.0042%

$8.91K

—

Lee June

Director

—

3,430

0.0042%

$8.91K

—

Individual transactions

Nothing of that kind in this period.

What was left out

Form 4 filings counted 120

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 9

Sales on a Rule 10b5-1 plan 0

Sales straight out of an exercise 0

Sales at will 10

Transactions with no price 6

Shares from compensation/vesting 4,733,149

Sales filed before the plan box existed 10

History held since 11 May 2017